Cargando…
A critical appraisal on AIT in childhood asthma
ABSTRACT: Allergen immunotherapy (AIT) is the only disease-modifying treatment approved for allergic rhinitis and allergic asthma and represents a suitable therapeutic option, especially in childhood, to modify the progression of respiratory allergic diseases. Starting from the previous “generic cla...
Autores principales: | Ferrando, Matteo, Racca, Francesca, Madeira, Lorena Nascimento Girardi, Heffler, Enrico, Passalacqua, Giovanni, Puggioni, Francesca, Stomeo, Niccolò, Canonica, Giorgio Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839070/ https://www.ncbi.nlm.nih.gov/pubmed/29527129 http://dx.doi.org/10.1186/s12948-018-0085-8 |
Ejemplares similares
-
Interleukin-5 in the Pathophysiology of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2019) -
AIT (allergen immunotherapy): a model for the “precision medicine”
por: Passalacqua, Giovanni, et al.
Publicado: (2015) -
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
por: Bagnasco, Diego, et al.
Publicado: (2017) -
Immunostimulants in respiratory diseases: focus on Pidotimod
por: Puggioni, Francesca, et al.
Publicado: (2019) -
Mepolizumab in the management of severe eosinophilic asthma in
adults: current evidence and practical experience
por: Varricchi, Gilda, et al.
Publicado: (2016)